摘要
Simple Summary Glioma prognosis and treatment are based on histopathological characteristics and molecular profile. Following the World Health Organization (WHO) guidelines (2016), the most important molecular diagnostic markers include IDH1/2-genotype and 1p/19q codeletion status, although more recent publications also include ARTX genotype and TERT- and MGMT promoter methylation. Machine learning algorithms (MLAs), however, were described to successfully determine these molecular characteristics non-invasively by using magnetic resonance imaging (MRI) data. The aim of this review and meta-analysis was to define the diagnostic accuracy of MLAs with regard to these different molecular markers. We found high accuracies of MLAs to predict each individual molecular marker, with IDH1/2-genotype being the most investigated and the most accurate. Radiogenomics could therefore be a promising tool for discriminating genetically determined gliomas in a non-invasive fashion. Although encouraging results are presented here, large-scale, prospective trials with external validation groups are warranted. Treatment planning and prognosis in glioma treatment are based on the classification into low- and high-grade oligodendroglioma or astrocytoma, which is mainly based on molecular characteristics (IDH1/2- and 1p/19q codeletion status). It would be of great value if this classification could be made reliably before surgery, without biopsy. Machine learning algorithms (MLAs) could play a role in achieving this by enabling glioma characterization on magnetic resonance imaging (MRI) data without invasive tissue sampling. The aim of this study is to provide a performance evaluation and meta-analysis of various MLAs for glioma characterization. Systematic literature search and meta-analysis were performed on the aggregated data, after which subgroup analyses for several target conditions were conducted. This study is registered with PROSPERO, CRD42020191033. We identified 724 studies; 60 and 17 studies were eligible to be included in the systematic review and meta-analysis, respectively. Meta-analysis showed excellent accuracy for all subgroups, with the classification of 1p/19q codeletion status scoring significantly poorer than other subgroups (AUC: 0.748, p = 0.132). There was considerable heterogeneity among some of the included studies. Although promising results were found with regard to the ability of MLA-tools to be used for the non-invasive classification of gliomas, large-scale, prospective trials with external validation are warranted in the future.
学科与关键词
- Noninvasive Determination of IDH and 1p19q Status of Lower-grade Gliomas Using MRI Radiomics: A Systematic ReviewBhandari, A. P.*; Liong, R.; Koppen, J.; Murthy, S. V.; Lasocki, A.AJNR. American journal of neuroradiology, 2021, 42(1): 94-101.被引 54
- Qualitative and Quantitative MRI Analysis in IDH1 Genotype Prediction of Lower-Grade Gliomas: A Machine Learning ApproachCao, Mengqiu; Suo, Shiteng; Zhang, Xiao; Wang, Xiaoqing; Xu, Jianrong; Yang, Wei*; Zhou, Yan*Biomed Research International, 2021, 2021: 1235314.被引 3
- MRI-Based Deep-Learning Method for Determining Glioma MGMT Promoter Methylation StatusYogananda, C. G. B.; Shah, B. R.; Nalawade, S. S.; Murugesan, G. K.; Yu, F. F.; Pinho, M. C.; Wagner, B. C.; Mickey, B.; Patel, T. R.; Fei, B.; Madhuranthakam, A. J.; Maldjian, J. A.*AJNR. American journal of neuroradiology, 2021, 42(5): 845-852.被引 54
